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GRAPHICAL ABSTRACT
Drug release mechanisms of chemically cross-linked albumin microparticles: effect of the matrix erosion
Danielly L. A. Sitta, Marcos R. Guilherme,  Elisangela P. da Silva, Artur J. M. Valente,  Edvani C. Muniz,and 
Adley F. Rubira
251658240
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Research Highlights
Albumin (BSA) microparticles were obtained in a W/O emulsion without and with PVA
BSA played a role as a surface active agent for W/O emulsion, replacing PVA
The microparticles showed a two-stage drug release profile at pH 2, 6 and 10
The two-step release mechanism is a characteristic of the BSA microparticles
The second release stage is a contribution of the matrix erosion 
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Abstract
Albumin (BSA) microparticles were developed as a biotechnological alternative for drug delivery. Vitamin B12
(Vit-B12) was used as a model drug. The microparticles were obtained from maleic anhydride-functionalized 
BSA and N’,N’-dimethylacrylamide (DMAAm)  in a W/O emulsion without and with PVA. The microparticles 
produced at 15 min of stirring without PVA showed the best results in terms of size, homogeneity, and 
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sphericity. In such a case, BSA played a role as a surface active agent, replacing PVA. For longer stirring 
times, BSA was unable to act as an emulsifier.
These microparticles showed an uncommon release profile, consisting of a two-step release mechanism, at 
the pH range studied. Considering that a two-step release mechanism is occurring, the experimental data 
were adjusted by applying modified power law and Weibull equations in order to describe release 
mechanism n and release rate constant k, respectively. Each one of the release stages was related to a 
specific value of n and k. The second stage was driven by a super case II transport mechanism, as a result of 
diffusion, macromolecular relaxation, and erosion. A third model, described by Hixson-Crowell, confirmed 
the erosion mechanism. 
Vit-B12 diffusion kinetics in aqueous solutions (i.e., without the microparticles) follows a one-step process, 
being k dependent on the pH, confirming that the two-step release mechanism is a characteristic profile of 
the developed microparticles. The microparticles released only 2.70% of their initial drug load at pH 2, and 
58.53% 
at pH 10. 
Keywords: Albumin; drug delivery; emulsion; erosion; microparticles; drug release kinetics
Introduction
One of the most promising areas of particles is the research and development of new pharmaceutical 
formulations, being that the main application is aimed towards the drug delivery. Among the various 
materials used in the production of nano and microparticles, there has been a considerable interest in the 
proteins as a starting substance for synthesis of more sophisticated release systems that may preserve the 
molecular structure of more potent and specific drugs [1]. This is because the protein-based materials are 
biodegradable, nonantigenic, and susceptible to metabolization, and also are able to be chemically modified 
by surface reaction for further covalent fixation of drugs and/or ligands [2].
Serum albumins are the most studied and applied proteins owing to their wide availability, low cost, good 
structural stability, binding properties with unusual ligands, biodegradability, and non-antigenicity [3, 4-6].
There is a great deal of interest both from a large segment of the pharmaceutical industry and from 
researchers in the area of biotechnology in the application of albumin as a drug carrier [7]. A remarkable 
property of albumin is its ability to reversibly bond to a wide variety of molecules [8], which is an interesting 
characteristic for drug delivery systems. Both bovine serum albumin (BSA) and human serum albumin (HSA) 
are used in the production of nano/microparticles [1-3, 9-12] in view of their structural similarity that 
corresponds to 75% of the homologous sequence. BSA is more suitable for in vivo tests due to its lower cost. 
To synthetize BSA particles, a radical cross-linking/polymerization approach in a hydroalcoholic emulsion 
was used, owing its advantages for ease and quick preparation [13]. The stability of an emulsion is related 
both to chemical nature of interfacial film and to attraction/repulsion force balance occurring among the 
particles suspended in the liquid, which are important in the prevention of the coalescence [14].
Surfactants (also called emulsifying agents) adsorb on interface reducing the interfacial tension. Many 
amphiphilic substances that form films are stabilizers for emulsions. Some exemples are proteins (BSA, 
casein), glucosides, lipids, steroids, calcium carbonate, glycerol, mercuric iodide [14], and polymers such as 
poly(vinyl alcohol) (PVA). The advantages of the polymerization in the emulsion include: (i) quick 
polymerization, (ii) products with a high molecular weight [13], and (iii) well-defined stages and simple 
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preparation. Thus, the polymerization in emulsion is an attractive approach to produce microparticles from 
hydrophilic natural materials [15].
This work aimed at producing protein microparticles from BSA using a hydroalcoholic emulsion for use in 
drug delivery systems. Vitamin B12 (Vit-B12) was used as the model drug. To obtain such a system, BSA was 
modified with maleic anhydride (MAy) in water, because only a small number of proteins may sustain 
dissolution in an organic medium without their molecular recognition properties being lost [16]. The 
nucleophilic groups in BSA, which could react with MA, are thiols of cysteine, hydroxyls of serine and 
tyrosine, and amines in the side chains of lysine [17]. However, the thiol groups (seventeen of them) are 
involved in disulfide bridges that aid to support the tertiary structure of the protein, except cys-34, because 
its hydroxyls are less nucleophilic and do not react under mild experimental conditions. In the present work, 
the reaction was processed at temperature of 37 ºC and at pH 5.5.  In such a case, only a small number of 
accessible sterically amine groups in the side chains of lysine react under such conditions [17]. In the light of 
this assessment, it could be said that MAy bonds to amine groups of lysine in BSA by nucleophilic reaction 
introducing its functional groups to the protein structure. The bindings between the functionalized BSA and 
DMAAm are of covalent nature. The advantage of covalent bindings is that they are stable with time. The 
idea was to use the vinyl bonds in functionalized BSA (BSAMAy) as a radical cross-linking/polymerization 
approach for reaction with N’,N’-dimethylacrylamide (DMAAm) in the emulsion. Figure 1 shows a schema of 
the chemical reactions for the cross-linking of BSA. Inside particle, DMAAm serves as a network support, 
owing to its good gelling capacity, and do not affect the original properties of the protein such as
biocompatibility and biodegradability. Furthermore, DMAAm is a safe material for use in drug delivery 
systems and is more indicated for such applications than acrylamide that has a great potential to cause 
cancer. Furthermore, DMAAm has been widely used in the preparation of biomaterials [18-20]. 
Insert Figure 1
Materials and Methods
Materials
Bovine serum albumin, BSA (Mw  68,000 g mol-1, ≥98.0%), maleic anhydride, MAy (≥99.0%), 
ammonium persulfate, APS, (≥98.0%) and vitamin B12 (≥98.5%) were purchased from Sigma-
Aldrich. N’,N’-dimethylacrylamide, DMAAm (99 %) and poly(vinyl alcohol) - PVA (87-89% 
hydrolyzed, Mw  31.000 g mol-1) were obtained from Aldrich. Benzyl alcohol (99.0%) and absolute 
ethyl alcohol (≥99.3%) were supplied by Fmaia, whilst N,N,N’,N’-tetramethylethylenediamine, 
TEMED (d = 0.780 g.mL-1, ≥99.0%) was obtained from Invitrogen. For buffer solutions, sodium 
phosphate, dibasic, anhydrous (98.0%) were supplied by Nuclear, and potassium phosphate, 
monobasic, (99.0%) from Labsynth. Buffer solutions of pH 7 and 10 were obtained from Synth. The 
hydrochloric acid (36.5-38.0%) and sodium chloride (Synth, 99.0%) were supplied by Chemco and 
Synth, respectively. All chemical were used as received.
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Functionalization of BSA with MAy (BSAMAy)
Protein-functionalizing solution was prepared by adding 0.5 g of BSA and 0.05 g of MAy to a phosphate 
buffer solution (0.1 M) with pH 5.5 while stirring. After homogenization, the solution was stirred for 3 h at 
37 ºC. The obtained product was precipitated with cold ethanol (2 °C), subsequently separated by 
centrifugation at 9500 rpm, and washed with deionized-distilled water three times. 
Preparation of protein microparticles using BSAMAy and DMAAm 
After lyophilization, 0.1 g of BSAMAy was added to 5 mL of phosphate buffer solutions at pH 7.0 at 20°C while 
stirring. The buffer solutions were previously prepared, but using different amounts of PVA (stabilizing 
agent) such as 0%, 1% and 2% (w/v). Then, 52 µL of DMAAm were incorporated under inert atmosphere of 
argon. After the mixture turned to a transparent, clear solution, 20 mL of benzyl alcohol were added 
dropwise while stirring so that a whitish emulsion was immediately formed. After 30 min, 0.02 g of 
ammonium persulfate, as an initiating agent, and 12.5 µL of TEMED, as a catalytic agent, were added to 
emulsion that was stirred at 750 rpm with the use of a propeller-shaped stirrer with 60 mm of diameter. The 
thus obtained product was precipitated with cold ethanol (2 °C), separated by centrifugation at 9500 rpm, 
and washed with deionized-distilled water three times. Other microparticles were produced in the same 
way but using stirring times of 15, 30, 60, and 90 min. 
Loading of Vit-B12 onto the microparticles
Two efficient approaches may be used to load a given solute onto a polymer device: (i) post-loading 
approach (after the device processing), and (ii) in situ loading approach (during the device processing). The 
post-synthesis loading approach is performed by immersing the microparticles into a solution containing the 
drug of interest. In such a case, the drug diffusion into the microparticle occurs by absorption and/or 
adsorption. The efficiency of such a strategy is related to affinity of the drug for protein chains.  Here, the in 
situ loading approach was used in view that a more significant amount of the drug can be loaded. In the in 
situ loading one, the drug molecules are trapped into the BSA network over the cross-linking/polymerization 
of the protein chains. There is no binding between Vit-B12 and DMAAm. The carbon-carbon double bonds of 
Vit-B12 are connected to either a carbonyl group or chemical groups, which are stabilized by resonances with 
steric hindrance. The initial weight of Vit-B12 corresponded to 10% of the total weight of BSAMAy used in the 
microsphere-forming emulsion.
Vit-B12 release from the microparticles
For tests of release, 0.1 g of Vit-B12-loaded microparticles was added to 30 mL of buffer solutions at pH 2, pH 
6 or pH 10 at 37 °C, and subsequently introduced into a dialysis tube. The suspension-filled dialysis tube was 
fixed at the bottom of a glass reactor with 220 mL of the corresponding buffer solution at 37 °C. The external 
solution was stirred at 300 rpm using a magnetic stirrer. Then, aliquots of 5 mL were collected from the 
external solution at specified periods, and then absorption readings were made at 360 nm in a UV-Vis 
spectrophotometer (Biochron, Libra S12 model). After, the aliquots were brought back into the reactor to 
prevent variation of volume. 
Page 7 of 25
Ac
ce
pte
d M
an
us
cri
pt
Both the loading efficiency and the concentrations of Vit-B12 released from the microparticles were 
determined from an analytical curve correlating the absorption to the concentration of the drug in water. 
The molar extinction coefficient () specific to 360 nm wavelength was 2.3  104 M-1cm-1.
In vitro release mechanism and release kinetics 
To determine the release profile of Vit-B12, curves correlating the fraction of the released drug to time were 
elaborated. The time-dependent release curves were calculated by the ratio between the concentration of 
drug released at specific time and the concentration of drug released at equilibrium. The experimental data 
were adjusted by applying a modified simple power law Korsemeyer-Peppas (equation 1) (see Section for 
further details), which is the most simple and comprehensive model used to describe the release profile of 
drug from a polymer device [21-24].
            (1)
where Ct and Care the cumulative concentrations of solute released from the microspheres at a specified 
time and at equilibrium, respectively, k is a proportionality constant that describes geometric and structural 
characteristics, C0 represents the concentration of the released specie at the time-lag t0, and n is the 
diffusional coefficient used to interpret the release mechanism [21-24].
The equation 1 is applied to predict the release mechanism of devices with different geometric shapes, such 
as films, cylinders, discs and spheres, but it is restricted for the first 60% of released solute ( ) 
[21, 22].
The values of n depend on geometry of the device. The conceptual meanings of n for geometrical shapes of 
the device are summarized in Table 1. Fickian diffusion indicates that the release mechanism is controlled by 
diffusion, that is, the drug diffuses through layers of the device. Anomalous transport is the contribution of 
both Fickian diffusional and relaxational mechanisms. In case II transport, the mechanism is driven by 
macromolecular relaxation of the polymer chains, and is independent on time. Super case II transport
mechanism results of the contribution of diffusion, macromolecular relaxation, and erosion of the polymer 
device [22, 24, 25].
Insert Table 1
To describe the overall profile of the in vitro released drug, and in order to take into account that in several 
occasions a two-step mechanism is occurring, a slightly modified version of the Weibull function [26] has 
been used:
   (2)
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here, d and k’ are related to mechanism and release rate constant, respectively [27]. The equation 2 gives an 
insight into the diffusional mechanism, since k’ is closely related to the rate constant of release [28].
Physical-chemical characterizations 
Fourier transform infrared spectroscopy (FTIR)
FTIR spectra of BSA, BSAMAy and microparticles were recorded in a Bomem FT-IR model MB100 
spectrometer. All the samples were introduced as dry powders. Powdered samples were prepared into 
pellets with KBr. The spectra were acquired in triplicate and a total of 128 scans were run for each spectrum 
to reach the resolution of 4 cm-1.
1H Nuclear Magnetic Resonance (NMR) spectroscopy for BSAMAy
1H NMR spectra were recorded in a Varian spectrometer, model Mercury Plus BB 300 MHz, using a 
frequency of 300.059 MHz, an angle pulse of 90° and a relaxation delay of 30 s. For spectra 
acquisition, D2O solutions (0.7 mL) containing either 20 mg L
-1 of BSA or 20 mg L-1 of BSAMAy
were prepared using 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt ((TSP-d4 (0.05%)) as 
internal reference. The resonance assigned to water was suppressed by irradiation during the 
relaxation. 
Solid-state 13C-CP/MAS NMR spectroscopy for microparticles 
The solid-state 13C-CP/MAS NMR spectra of BSA, BSAMAy and microparticles were obtained using 
angle pulse of 37º, frequency of 75.45 MHz, contact time of 3 ms, and relaxation time of 3 s.
Measures of dynamic light scattering (DLS) and ζ- potential
Diluted suspensions of microspheres were prepared with addition of a very small quantity of sample to 1.5 
mL of water at room temperature while stirring. After 15 min of dispersion, the suspension became clear 
because of dilution. Later, 1.5 mL of the stirred suspension were introduced into a glass cell for DLS analysis. 
The diameters of water-dispersed particles were determined from intensity size distributions using a Nano 
Particle Size and Zeta Potential DLS analyzer from Particulate Systems. Data were processed with the use of 
a software supplied by own manufacturer. The readings of ζ- potential were made with the injection of 0.7 
mL into a standard sample flow cell under the desired temperature. The values were recorded at room 
temperature using stirred suspensions of microparticles. 
Scanning electron microscopy (SEM) for morphology
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Morphological characteristics of the lyophilized samples were analyzed in a scanning electron microscope 
(Shimadzu, model SS 550 Superscan). The samples were earlier sputter-coated with a thin layer of gold. SEM 
images were made applying an acceleration voltage of 15 kV and a current intensity of 30 µA. 
Results and discussion
Spectroscopic characterization of functionalized BSA and microparticles 
Figure 2(a) shows the FTIR spectra of BSA, BSAMAy, and microparticles prepared at stirring times of 15, 30, 60 
and 120 min. The band at 947 cm-1 in the FTIR spectrum of BSAMAy, attributed to bending vibration of 
disubstituted C=C groups, indicates the functionalization of the protein.  This band disappeared completely 
in the spectra of the microparticles after the cross-linking/polymerization reaction, because of the 
consumption of carbon-carbon -bond. Furthermore, this vibrational mode also suggests a trans
conformation [29], indicating a change from cis (original conformation) to trans owing to maleic anhydride 
ring-opening over the modification reaction. If the isomeric conformation of the double bond of MA 
supposedly was cis, a band of high intensity should appear in the region of 730-665 cm-1, owing to =C-H 
bending [29]. The presence of H2PO4-/HPO42- mineral acid in the phosphate buffer solution of pH 5.5, used in 
the reaction, could have influenced on the spatial conversion of the double bond, and this seems to be the 
case of BSAMAy. 
Figure 2(b) shows the 1H NMR of BSA and BSAMAy. The signals at δ 5.8 and δ 6.2 in the spectrum of BSAMAy
were assigned to vinyl carbon-bonded hydrogen resonances in the functionalized protein, which confirms 
the formation of BSAMAy, supporting the FTIR analysis. This approach was complemented by solid-state 13C-
CP/MAS NMR spectroscopy (Figure 2(c)). The signals at δ 127 and δ 132 were attributed to carbonyl carbon 
of acids in conjugated systems, which are absent in the original structure of BSA. The introduction of 
chemical groups from MAy to BSA creates vinyl acids          (-HC=CH-COOH) in the protein.
From the analysis of Figure 2(c) it can also be observed in the spectrum of BSAMAy a reduction of the 
resonance intensity at δ 29 ppm, and the appearance of a new resonance at δ 36. These spectral changes 
indicate that the amine groups in BSA reacted to form primary, secondary and tertiary amines in BSAMAy.  
The occurrence of the cross-linking polymerization reaction of BSAMAy with DMAAm was verified by the 
reduction in the intensity of the signal at δ 167 in the spectrum of microparticles, corroborating the FTIR 
data. Although the region of the vinyl groups (δ 127 and δ 132), in the spectrum of BSAMAy, was somewhat 
overlapped by signal of benzyl alcohol residues, in the spectrum of particles, significant changes may be 
observed in the same spectral region. This represents an additional evidence of the particle formation. 
Insert Figure 2
Microparticle Morphology 
The objective of using a W/O emulsion as a cross-linking/polymerization approach was based on the concept 
that this reaction medium is effective to produce polymer microparticles with an approximately spherical 
shape. Well-defined microparticles show regular mass distribution, which may prevent both anisotropic 
swelling and deviation of ideal release profile [11,30]. Furthermore, the size and shape of these 
microparticles could be improved with aid of partially hydrolyzed PVA [31].
In the emulsion cross-linking/polymerization, speed and time of stirring, and amount of surfactant affect the 
morphology of the microparticle. Here, the stirring speed used for protein-based microparticles was 
relatively low (750 rpm), compared with those of the literature:  6100 rpm [32], 1500 rpm [33], and 1000 
rpm [1, 11, 30]. From a physical chemical point of view, our present understanding is that the structural 
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integrity of BSA may be affected at a stirring speed higher than those that have been reported. However, 
stirring speeds lower than 750 rpm may not be enough to finely emulsify a W/O mixture.  
Figure 3 shows the SEM images of BSA, BSAMAy, and microparticles produced at different stirring times with 
and without PVA. The following conclusions can be taken from the SEM images: (i) BSA particles showed 
predominantly spherical shape with small size dispersity (Figure 3(c)), (ii) by increasing the stirring time from 
15 to 30 min, the surface of the particles became rough, with heterogeneous particle dimensions (Figure 
3(f)); (iii) a further increase of stirring time lead to particles with undefined shape (Figures 3(i) and 3(l)); (iv) 
those particles containing PVA showed an undefined shape (Figures 3(d-e)); (iv) by increasing the stirring 
time to 30 minutes, blend particles showed undefined shape and aggregation (Figures 3(g-h)); and (vi) 
increasing the stirring time for 60 and 120 minutes blend particles showed unshaped and heterogeneous 
size (Figures 3(j-k)) and heterogeneous size  (Figures 3(m-n)), respectively. 
The microparticles formed at 15 min without PVA showed the best results in terms of size, homogeneity, 
and sphericity. An important factor is that the proteins show emulsifying properties by adsorption on the 
water-oil interface, which forms a physical chemical barrier among the droplets and thus prevents the 
coalescence of the emulsion [34]. In such a case, BSA acted as a surface active agent. During the adsorption, 
the protein changes its structural conformation so that physical chemical interactions at the interface 
become more favorable [35,36]. 
The extent and speed at which the protein chains are rearranged at the interface are affected by several 
factors such as chain flexibility, distribution of hydrophilic/hydrophobic domains, and hydrophobicity of the 
oil phase. In general, the proteins lose its tertiary structure owing to adsorption at the interface, although 
significant amounts of non-native secondary structures are preserved [35, 37]. 
The emulsifying properties of BSA were preserved up to 30 min of stirring. Upon addition of PVA, there is an 
excess of emulsifier that affects the stability of the emulsion. Under this condition, the intermolecular 
attraction forces of the liquid increase, and the reaction medium coalesces. The efficiency of the protein in 
stabilizing emulsions depends on a variety of factors, such as concentration, pH, ionic strength, thermal 
treatment, stirring, and so forth [30]. We theorize that, with an increase in the stirring time from 60 to 120 
min, BSA became unable to act as an emulsifier owing to an excessive denaturation that could lead to 
precipitation, and thus PVA starts playing such a role. Therefore, PVA improves both sphericity and 
homogeneity of the microparticles synthetized at longer stirring times. With the addition of PVA, there can 
be a competitive adsorption between the protein and the surfactant molecules at the interface, leading the 
emulsion to a destabilization [38,39].  
The proteins and emulsifiers stabilize emulsions by different mechanisms. The proteins may be adsorbed at 
the interface owing to their structural characteristics. It has been reported that the proteins are able to form 
a hydrated layer at the interface and that some of the side-chains of the hydrophobic residues can enter a 
small distance into oil phase.  The emulsifiers function by decreasing the interface tension and depends on 
the intramolecular repulsion forces among the polar groups [38,40]. 
Insert Figure 3
ζ- potential and dynamic light scattering (DLS)  
Page 11 of 25
Ac
ce
pte
d M
an
us
cri
pt
On the basis of the SEM results, only microparticles produced at 15 min of stirring without PVA were further 
analyzed by DLS and ζ- potential (Figure 4).  Figure 4(a) shows the ζ-potential curves of BSA, BSAMAy, and 
microparticles produced at 15 min without PVA. The ζ-potentials were measured in water at pH of nearly 7 
for all samples. Under this condition, BSA showed negative ζ- potential (10.49 ± 0.11), because, at pH 
above the isoelectric point, the acid groups of the amino acid residues in the protein undergo 
deprotonation. The ζ- potential became more negative in BSAMAy (33.77 ± 3.32), owing to reaction between 
free amine and maleic anhydride that introduced new carboxylic groups to the protein. In the 
microparticles, the ζ- potential changed to 17.05 ± 1.25. In such a case, the amine groups in DMAAm 
counterbalance, to some extension, the charges on the acid groups in BSA. 
Figure 4(b) shows the DLS curve of microparticles produced at 15 min without PVA. These microparticles 
showed an average diameter of 1.35 µm. As the particle diameter was on the order of micrometers, only a 
run was performed for that sample to prevent sedimentation or aggregation of particles in a layer at the 
bottom of the suspension, which leads to a larger particle size distribution.  
The micrometer-sized particles were formed by cross-linking/polymerization reaction at the droplets of 
alcohol-confined water in the emulsion, owing to hydrophilic nature of BSAMAy and DMAAm. The spherical 
shape of the microparticles results of a macromolecular fine-tuning of both reactants to water droplets 
during the reaction.
Insert Figure 4
Vit-B12 release from the microparticles
The microparticles showed a loading efficiency of 78.4 ± 1.5%, considering the initial Vit-B12 concentration 
added to the emulsion. Figures 5(a), (b) and (c) shows time-dependent release curves of Vit-B12 from the 
microparticles at 37 °C at different pH values. The experimental data were fitted according to equations 1 
and 2 in order to describe release mechanism n, and release rate constants k’1 (first stage) and k’2 (second 
stage), respectively. 
Tortuous release profiles, in which two release stages were described, were observed at the pH range 
studied. Each one of the release stages was related to a specific value of n and k, suggesting that the overall 
release profile of Vit-B12 from the protein-based microparticles is predicted by different types of mechanisms 
and release rates. These two step-release mechanisms have been found for release of DNA [41] and BSA and 
FITC-dextran [42] from DNA-based gels. Table 2 summarizes the data of n and k and other adjusting 
parameters for the two stages, where subscripts 1 and 2 represent the first and second stage, respectively. 
Insert Figure 5 and Table 2
Release rate constant (k) of Vit-B12
At pH 2 (Figure 5(a)), the values of k indicated a release rate faster in the beginning of the experiment, 
followed by a lag phase (or equilibrium) and a release rate approximately 8×10-3 times slower. The release 
rates at pH 6 (Figure 5(b)) and at pH 10 (Figure 5(c)) differ from those in the strongly acid medium. At pH 6, 
there was a slow release rate in which less than 10% of the total load of Vit-B12 was released, followed by a 
release rate two orders of magnitude faster until reaching the equilibrium. At pH 10, the release rate is 
initially slower and less than 20% of the drug is released, followed by a release rate approximately 52 times 
faster. The different release profiles result of both structural changes and charges generated on the polymer 
network of the microparticles, owing to changes at pH of the release medium. 
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The total cumulative release of Vit-B12 increased with increasing pH of the surrounding liquid. The 
microparticles released only 2.70% of their initial drug load at pH 2.  
The experimental data at different pH indicated that these microparticles have a great potential for uses in 
the systems that release drugs at the intestine, especially at the colon, where the environment is slightly 
alkaline. 
Release mechanism (n) of the model drug (Vit-B12)
The values of t∞ of Vit-B12 were larger at pH 2 (Figure 5(a)) and at pH 10 (Figure 5(c)). However, at pH 6 
(Figure 5(b)), twas slower than in both the acid and the basic media, owing to the lower liquid charge on 
BSA at pH close to its isoelectric point. Under this condition, the physical chemical affinities between BSA 
and Vit-B12 are minimized, and a larger load of the drug is released at a shorter time. 
The value of n (n1 = 0.71±0.02) at pH 2 (Figure 5(a)) indicated an anomalous mechanism for Vit-B12 release, 
coupling of Fickian diffusional and relaxational mechanisms. Only a value of n can be described for such pH, 
because the first release stage corresponded practically to first 60% of the released drug. This is a limit value 
for applicability of the equation 1. At pH 6 (Figure 5(b)), at the first release stage of the  curve vs
time, where the release reached 3% of the total release, the drug release follows a pseudo-Fickian 
mechanism (n1 = 0.22±0.01).  At the second stage, which corresponded to 60% of the total release, the 
mechanism is governed by super case II transport (n2 = 2.31±0.09), contributions of diffusion, 
macromolecular relaxation, and erosion. At pH 10, at the first stage, the anomalous mechanism was 
predominant (n1= 0.62±0.02). At the second stage, the release occurred by diffusion, macromolecular 
relaxation, and erosion (n2 = 5.29±0.11). These findings are according to those reported elsewhere [43,44]. It 
has been reported that the drug release from the hydrophilic polymer devices is result of a glassy-to-rubbery 
transition caused by water penetration into the device. The two most important factors which affect 
swellable polymer devices are water penetration (including hydration, gelatinization, and swelling) and 
erosion rates [43].
Influence of morphology on the release
To verify the influence of the morphology on the release, the samples were first swollen in buffer solutions 
of pH 2, pH 6 or pH 10 at 37 °C (same method of the release) and lyophilized before observation by SEM. In 
those conditions, it is assumed that the morphology of the swollen samples were preserved, that is, the 
actual morphology of the microparticles suspended in the liquid.  
Figure 6(a) shows the SEM images of the lyophilized microparticles (15 min, 0% PVA) after swelling for 24 h 
at pH 2, pH 6 or pH 10 at 37 °C. 
The microparticles degraded after swelling at pH range studied. The swollen particles became larger 
(compared with those of Fig. 3(a)) and showed a hollow center. This morphology results of a burst of 
vesicular structure, as a consequence of osmotic pressure during the swelling. 
Further insight into the release mechanism is obtained by fitting the amount of drug remaining in the 
matrix at time t, Q, to the Hixson-Crowell cubic root equation [45]:
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where Q0 is the amount of drug in the matrix at t = 0 and kC is the cube root law rate constant. This equation 
describes the release from systems where a change in surface area and diameter of particles occurs.
Figure 6(b) shows the cube root of Vit-B12 remaining in the albumin microparticles plotted against time. It is 
also be expectable that the Vit-B12 release will change, by dissolution, the surface area and gel matrix 
dimensions. In fact, a good fitting to the Hixson-Crowell cubic root equation (equation 3) is obtained 
confirming that assumption. Furthermore, the applicability of the data to Hixson-Crowell model 
corroborates the argument that, for each pH, there are two distinct release stages. It is also possible to 
conclude that, in view of the mathematical fit, the erosion occurs by erosion of two layers.
Vit-B12 diffusion outwards dialysis tube
To check a possible influence of the dialysis tube on the tortuous release profile, 0.01 g of Vit-B12 was added 
to 30 mL of buffer solutions with pH 2, pH 6 or pH 10 at 37 °C while stirring. The conditions of the analysis 
were the same of the release method, but in the absence of microparticles. The Vit-B12 diffusion was 
monitored by spectrophotometry at 360 nm, and its concentrations were determined from the analytical 
curve. The data were shown in Figure 6(c). 
The Vit-B12 diffusion outwards dialysis tube exponentially increased with time and only a value of k can be 
described for each pH:  1.44×10-3 min-1 for pH 2, 1.05×10-3 min-1 for pH 6, and 9.91×10-4 min-1 for pH 10. 
These values were almost in the same order of magnitude for the pH range analyzed, indicating that the 
tortuous release profile is a characteristic of the developed microparticles. Furthermore, the exponential-
like diffusion curves indicated that the Vit-B12 do not undergoes degradation. 
Insert Figure 6
Conclusions 
BSA microparticles with an average diameter of 1643 µm were produced using vinylated BSA and DMAAm in 
the hydroalcolic emulsion, under a stirring speed of 750 rpm, for applications in drug delivery. The 
microparticles (15 min of stirring, 0% PVA) showed the best results in terms of size, homogeneity, and 
sphericity. In such a case, BSA played a role as a surface active agent, replacing PVA. The emulsifying 
properties of BSA were preserved up to 30 min. For longer stirring times, BSA became unable to act as an 
emulsifier, and PVA started playing this role. 
BSA showed negative ζ- potential (10.49 ± 0.11), because of the deprotonation of acid groups in the amino 
acid residues at pH 5.5. The ζ- potential became more negative in BSAMAy (33.77 ± 3.32), owing to reaction 
between free amine and maleic anhydride that introduced new carboxylic groups to the protein. In the 
microparticles, the ζ- potential changed to 17.05 ± 1.25, as a result of the amine groups in DMAAm that 
counterbalanced the charges on the acid groups in BSA. 
Tortuous release profiles, in which two release stages were described, were observed at the pH range 
studied. The different release profiles, in a same kinetic curve, result of both structural changes and charges 
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generated on the polymer network of the microparticles owing to changes at pH. The second stage is driven 
by a super case II transport mechanism, as a result of diffusion, macromolecular relaxation, and erosion. 
Hixson-Crowell model confirmed the erosion mechanism of the microparticles. The swollen particles 
became larger and showed a hollow center. This morphology results of a burst of vesicular structure, as a 
consequence of osmotic pressure during the swelling.
The Vit-B12 diffusion outwards dialysis tube, without microparticles, exponentially increased with time, 
indicating that the tortuous release profile is a characteristic of the microparticles. The microparticles 
released only 2.70% of their initial drug load at pH 2, and 58.53% at pH 10. 
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Figure Captions
Figure 1: Strategy for the preparation of chemically cross-linked BSA microparticles. (a) Nucleophilic reaction 
of amine group of lysine in BSA with MA. (b) Radical ions 
(I-) attacking to vinyl groups in MA-modified BSA. (c) The resultant BSA macroradical reacts with DMAAm 
monomers molecules by cross-linking/polymerization reaction to form covalent BSA microparticles.
Figure 2: (a) FTIR spectra of BSA, BSAMAy, and microparticles produced at different times of stirring without 
PVA. (b) 1H NMR spectra of BSA and BSAMAy. (c) Solid-state 13C-CP/MAS NMR spectra of BSA, BSAMAy, and 
microparticles (15 min, 0% PVA).
Figure 3: SEM images of BSA (a), and BSAMAy (b). The microparticles produced at different stirring times with 
and without PVA were shown in (c) 15 min, 0% PVA; (d) 15 min, 1% PVA; (e) 15 min, 2% PVA; (f) 30min, 0% 
PVA; (g) 30 min, 1% PVA; (h) 30 min, 2% PVA; (i) 60 min, 0% PVA; (j) 60 min, 1%; (k) 60 min, 2% PVA; (l) 120 
min, 0% PVA; (m) 120 min, 1% PVA; and (n) 120 min, 2% PVA.
Figure 4: ζ-potential (a) and DLS (b) curves of albumin microparticles (15 min, 0% PVA). 
Figure 5: Time-dependent release curves of Vit-B12 from the albumin microparticles (15 min, 0% PVA) at 37 
°C for pH 2 (a), pH 6 (b), and pH 10 (c). 
Figure 6: (a) SEM images of the lyophilized albumin microparticles (15 min, 0% PVA) after swelling at 37 °C at 
the indicated pH  for an incubation period of 24 h. (b) Hixson-Crowell cube root plots of Vit-B12 release from 
the albumin microparticles (15 min, 0% PVA) 37 °C. (c) Time-dependent diffusion curves of Vit-B12 outwards 
dialysis tube at 37 °C.    
Table Captions
Table 1: Values of diffusional exponent, n, for polymer devices with different geometrical shapes.
Table 2: Fitting parameters of equations (1) and (2) to Vit-B12 release from the microparticles of BSA and 
DMAAm (15 min, 0% PVA) at the two stages: time necessary to cumulative release of Vit-B12 to reach 
equilibrium (t∞), total cumulative release of Vit-B12 (%), diffusional coefficient (n) and release rate constants 
(k1 and k2). 
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Table 1 
Diffusional exponent n 
 
Release mechanism Thin film Cylinder Sphere 
0.5 0.45 0.43 Fickian diffusion 
0.5 < n < 1.0 0.45 < n < 0.89 0.43 < n < 0.85 
Anomolous transport (non-
Fickian) 
1.0 0.89 0.85 
Case II transport (zero-order 
release) 
> 1.0 > 0.89 > 0.85 Super case II transport 
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Table 2 
 pH 
 2 6 10 
t∞ (min) 2988 (±53, n=2) 2198 (±73, n=2) 5720 (±94, n=2) 
Cumulative release (%)  2.70 (±0.12, n=2) 47.70 (±0.33, n=2) 58.53 (±0.46, n=2) 
n1 0.71 (±0.02, n=2) 0.22 (±0.01, n=2) 0.62 (±0.02, n=2) 
n2 - 2.31 (±0.09, n=2) 5.29 (±0.11, n=2) 
k1 (min-1) 1.02×10-2 (±2.23×10-4, 
n=2) 
1.53×10-6(±5.31×10-8, 
n=2) 
3.97×10-6 (±1.12×10-7, 
n=2) 
k2 (min-1) 7.75×10-5 (±2.15×10-6, 
n=2) 
2.17×10-4 (±0.05×10-5, 
n=2) 
2.06×10-4 (±0.09×10-5, 
n=2) 
The fitting parameters were estimated by a least-squares approach, with a 95% level of 
confidence (Origin 8.0). 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
